Fundraising FoxBioAdvance — 2019 Investments
2 investments dated 2019 · listed companies and verified rows first · show all
Kayo Therapeutics is a biotechnology company developing therapeutics, with a scientific and clinical focus that includes areas such as metabolic disease and oncology.
BiotechHealthtechSeattle, US
Mark Esposito(CSO, Co-Founder and Board Member)inYibin Kang(Chair, Scientific Advisory Board and Co-Founder)Kendall Mohler(Executive Officer, Director)Thong Q. Le(President and CEO, Board Member)Ian Howes(Chief Financial Officer)Merika Koday(COO and Board Member)in
Co-investors7G BioVenturesFoundation Venture Capital Group, LLC
Ermit designs and manufactures connected hardware devices with embedded software and AI capabilities, serving companies building IoT and field-operated products.
CybersecurityHardwareIoTNew York, IT
Emanuele Musini(CEO and Director)James Wyman(CFO and Director)
BoardYogendra Jain(Director)
Co-investorsCivilization Ventures Management, LlcHackensack Meridian Health Bear's DenHikma VenturesSamsung VenturesStanley Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.